Albizzati E, Breccia M, Florio E, Cabasino C, Postogna FM, Grassi R, Boda E, Battaglia C, De Palma C, De Quattro C, Pozzi D, Landsberger N, Frasca A (2024) Mecp2 knock-out astrocytes affect synaptogenesis by interleukin 6 dependent mechanisms. iScience 27(3):109296. https://doi.org/10.1016/j.isci.2024.109296

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allison K, Maletic-Savatic M, Pehlivan D (2024) MECP2-related disorders while gene-based therapies are on the horizon. Front Genet 15:1332469. https://doi.org/10.3389/fgene.2024.1332469

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bauer M, Kölsch U, Krüger R, Unterwalder N, Hameister K, Kaiser FM, Vignoli A, Rossi R, Botella MP, Budisteanu M, Rosello M, Orellana C, Tejada MI, Papuc SM, Patat O, Julia S, Touraine R, Gomes T, Wenner K, Xu X, von Bernuth H (2015) Infectious and immunologic phenotype of MECP2 duplication syndrome. J Clin Immunol 35(2):168–181. https://doi.org/10.1007/s10875-015-0129-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown K, Selfridge J, Lagger S, Connelly J, De Sousa D, Kerr A, Webb S, Guy J, Merusi C, Koerner MV, Bird A (2016) The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndrome. Hum Mol Genet 25(3):558–570. https://doi.org/10.1093/hmg/ddv496

Article  CAS  PubMed  Google Scholar 

Cascio L, Chen CF, Pauly R, Srikanth S, Jones K, Skinner CD, Stevenson RE, Schwartz CE, Boccuto L (2020) Abnormalities in the genes that encode large amino acid transporters increase the risk of autism spectrum disorder. Mol Genet Genom Med 8(1):e1036. https://doi.org/10.1002/mgg3.1036

Article  Google Scholar 

Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Sci (New York N Y) 320(5880):1224–1229. https://doi.org/10.1126/science.1153252

Article  CAS  Google Scholar 

Chinta SJ, Andersen JK (2005) Dopaminergic neurons. Int J Biochem Cell Biol 37(5):942–946. https://doi.org/10.1016/j.biocel.2004.09.009

Article  CAS  PubMed  Google Scholar 

Collins BE, Neul JL (2022) Rett syndrome and MECP2 duplication syndrome: disorders of MeCP2 dosage. Neuropsychiatr Dis Treat 18:2813–2835. https://doi.org/10.2147/NDT.S371483

Article  PubMed  PubMed Central  Google Scholar 

Ehrhart F, Coort SL, Cirillo E, Smeets E, Evelo CT, Curfs LM (2016) Rett syndrome - biological pathways leading from MECP2 to disorder phenotypes. Orphanet J Rare Dis 11(1):158. https://doi.org/10.1186/s13023-016-0545-5

Article  PubMed  PubMed Central  Google Scholar 

Eulenburg V, Armsen W, Betz H, Gomeza J (2005) Glycine transporters: essential regulators of neurotransmission. Trends Biochem Sci 30(6):325–333. https://doi.org/10.1016/j.tibs.2005.04.004

Article  CAS  PubMed  Google Scholar 

Frasca A, Miramondi F, Butti E, Indrigo M, Balbontin Arenas M, Postogna FM, Piffer A, Bedogni F, Pizzamiglio L, Cambria C, Borello U, Antonucci F, Martino G, Landsberger N (2024) Neural precursor cells rescue symptoms of Rett syndrome by activation of the Interferon γ pathway. EMBO Mol Med 16(12):3218–3246. https://doi.org/10.1038/s44321-024-00144-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gold WA, Percy AK, Neul JL, Cobb SR, Pozzo-Miller L, Issar JK, Ben-Zeev B, Vignoli A, Kaufmann WE (2024) Rett syndrome. Nat Reviews Disease Primers 10(1):84. https://doi.org/10.1038/s41572-024-00568-0

Article  PubMed  Google Scholar 

Golubiani G, Lagani V, Solomonia R, Müller M (2021) Metabolomic fingerprint of Mecp2-Deficient mouse cortex: evidence for a pronounced multi-facetted metabolic component in Rett syndrome. Cells 10(9):2494. https://doi.org/10.3390/cells10092494

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gottschalk I, Kölsch U, Wagner DL, Kath J, Martini S, Krüger R, Puel A, Casanova JL, Jezela-Stanek A, Rossi R, Chehadeh SE, Van Esch H, von Bernuth H (2023) IRAK1 duplication in MECP2 duplication syndrome does not increase canonical NF-κB-Induced inflammation. J Clin Immunol 43(2):421–439. https://doi.org/10.1007/s10875-022-01390-7

Article  CAS  PubMed  Google Scholar 

Harris E (2023) Trofinetide receives FDA approval as first drug for Rett syndrome. JAMA 329(14):1142. https://doi.org/10.1001/jama.2023.4003

Article  PubMed  Google Scholar 

Horvath PM, Monteggia LM (2018) MeCP2 as an activator of gene expression. Trends Neurosci 41(2):72–74. https://doi.org/10.1016/j.tins.2017.11.005

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hudu SA, Elmigdadi F, Qtaitat AA, Almehmadi M, Alsaiari AA, Allahyani M, Aljuaid A, Salih M, Alghamdi A, Alrofaidi MA, Abida, Imran M (2023) Trofinetide for Rett syndrome: highlights on the development and related inventions of the first USFDA-approved treatment for rare pediatric unmet medical need. J Clin Med 12(15):5114. https://doi.org/10.3390/jcm12155114

Article  CAS  PubMed  PubMed Central  Google Scholar 

Illescas S, Diaz-Osorio Y, Serradell A, Toro-Soria L, Musokhranvoa U, Juliá-Palacios N, Ribeiro-Constante J, Altafaj X, Olivella M, O’Callaghan M, Darling A, Armstrong J, Artuch R, García-Cazorla À, Oyarzábal A (2023) Metabolic characterization of neurogenetic disorders involving glutamatergic neurotransmission. J Inherit Metab Dis. https://doi.org/10.1002/jimd.12689Advanced online publication

Article  PubMed  Google Scholar 

Jain A, Kaczanowska S, Davila E (2014) IL-1 receptor-associated kinase signaling and its role in inflammation, cancer progression, and therapy resistance. Front Immunol 5:553. https://doi.org/10.3389/fimmu.2014.00553

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanehisa M (2019) Toward understanding the origin and evolution of cellular organisms. Protein Science: Publication Protein Soc 28(11):1947–1951. https://doi.org/10.1002/pro.3715

Article  CAS  Google Scholar 

Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28(1):27–30. https://doi.org/10.1093/nar/28.1.27

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M (2023) KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res 51(D1):D587–D592. https://doi.org/10.1093/nar/gkac963

Article  CAS  PubMed  Google Scholar 

Kaur S, Christodoulou J (2001) MECP2 disorders. In: Adam MP et al (eds) GeneReviews®. University of Washington, Seattle

Krishnaraj R, Ho G, Christodoulou J (2017) RettBASE: Rett syndrome database update. Hum Mutat 38(8):922–931. https://doi.org/10.1002/humu.23263

Article  PubMed  Google Scholar 

Legendre P (2001) The glycinergic inhibitory synapse. Cell Mol Life Sci 58:760–793

CAS  PubMed  PubMed Central  Google Scholar 

Leonard H, Silberstein J, Falk R, Houwink-Manville I, Ellaway C, Raffaele LS, Engerström IW, Schanen C (2001) Occurrence of Rett syndrome in boys. J Child Neurol 16(5):333–338. https://doi.org/10.1177/088307380101600505

Article  CAS  PubMed  Google Scholar 

Leonard H, Cobb S, Downs J (2017) Clinical and biological progress over 50 years in Rett syndrome. Nat Reviews Neurol 13(1):37–51. https://doi.org/10.1038/nrneurol.2016.186

Article  CAS  Google Scholar 

Li Puma DD, Colussi C, Bandiera B, Puliatti G, Rinaudo M, Cocco S, Paciello F, Re A, Ripoli C, De Chiara G, Bertozzi A, Palamara AT, Piacentini R, Grassi C (2023) Interleukin 1β triggers synaptic and memory deficits in herpes simplex virus type-1-infected mice by downregulating the expression of synaptic plasticity-related genes via the epigenetic MeCP2/HDAC4 complex. Cell Mol Life Sci 80(6):172. https://doi.org/10.1007/s00018-023-04817-5

Article  CAS  PubMed  PubMed Central